Upload
Featured Recent Articles Topics Login Upload

Search Results for 'cancer egfr'

cancer egfr published presentations and documents on DocSlides.

EGFR Mutation in Lung Adenocarcinoma (ADC)
EGFR Mutation in Lung Adenocarcinoma (ADC)
by QuietConfidence
Ana Rima. Lung Cancer: Incidence and Mortality. Ne...
Best Practices in Nursing Management of EGFR Inhibitor Rash
Best Practices in Nursing Management of EGFR Inhibitor Rash
by olivia-moreira
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pr...
Anti-EGFR induced skin
Anti-EGFR induced skin
by berey
toxicity. ESDO Learning Bytes 2021. Dr Violaine RA...
Mechanisms of resistance to EGFR
Mechanisms of resistance to EGFR
by conchita-marotz
TKI. s. . and . related. . treatment . strategi...
CD3-EGFR Probody™ T Cell-engaging Bispecific Induces Tumo
CD3-EGFR Probody™ T Cell-engaging Bispecific Induces Tumo
by karlyn-bohler
Increases . Safety Window in Preclinical Studies....
Audit of EGFR mutation testing in patients with proven Non-
Audit of EGFR mutation testing in patients with proven Non-
by aaron
On behalf of the North of England Cancer Network ...
Lung cancer Treatment
Lung cancer Treatment
by attentionallianz
Consequences of the Lack of Patients of color &...
Detection of Mutations in EGFR in Circulating Lung-Cancer C
Detection of Mutations in EGFR in Circulating Lung-Cancer C
by sherrill-nordquist
Colin Reisterer and Nick Swenson. S. . Maheswaran...
Mechanistic Insights into Oncogenic Activation of Epidermal
Mechanistic Insights into Oncogenic Activation of Epidermal
by ripplas
Growth Factor Receptor (EGFR) mutants and its Clin...
METHODS Conclusion INTRODUCTION
METHODS Conclusion INTRODUCTION
by anderson
ACKNOWLEDGEMENTS. REFERENCES. Leslie . Dunc...
Squamous-cell
Squamous-cell
by debby-jeon
carcinoma. - . new. . biomarkers. Rafal. . Dzi...
Jchem applications in Medchem
Jchem applications in Medchem
by StarsAndStripes
Prediction. . and. . Data Sorting. Zhengtao. Li...
Defining Epidermal Growth Factor Receptor exon 20 mutant se
Defining Epidermal Growth Factor Receptor exon 20 mutant se
by trish-goza
k. inase . i. nhibition. Danny Rayes . Lung Cance...
Using Non-targeted Therapies in Targeted Lung Cancer Popula
Using Non-targeted Therapies in Targeted Lung Cancer Popula
by ellena-manuel
Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...
Acquired Resistance Patient Forum
Acquired Resistance Patient Forum
by test
September 6, 2014 | Boston. In ALK, ROS1 & EG...
Thierry
Thierry
by cheryl-pisano
Le Chevalier, . MD. The Role of Translational Res...
Surrogate or Not: The Role for
Surrogate or Not: The Role for
by cheryl-pisano
Cell Free Circulating . DNA in Detecting EGFR Mut...
EGFR-Mediated Reactivation of MAPK Signaling Contributes to
EGFR-Mediated Reactivation of MAPK Signaling Contributes to
by ellena-manuel
BRAF. -Mutant Colorectal Cancers to RAF Inhibitio...
Treatment in Advanced Non-Small Cell Lung Cancer
Treatment in Advanced Non-Small Cell Lung Cancer
by oconnor
. 5. th. most commonly diagnosed cancer in Austra...
Multidisciplinary approach to lung cancer
Multidisciplinary approach to lung cancer
by elena
Kamil Konopka. Department of Oncology, University ...
Environmental Cancers Melanoma and Lung Cancer
Environmental Cancers Melanoma and Lung Cancer
by dorothy
Lara K. . Goudsouzian. , Ph.D.. Associate Professo...
SPN and Lung Cancer Adam J. Hayek, DO
SPN and Lung Cancer Adam J. Hayek, DO
by sequest
PGY-6. Pulmonary and Critical Care Fellow . GOALS....
ALK in lung cancer: Past, present, and future
ALK in lung cancer: Past, present, and future
by belinda
Gene Mutations in Lung . Adenocarcinomas. 17 years...
Class 12 DNA sequencing and cancer
Class 12 DNA sequencing and cancer
by tatyana-admore
DNA pol error rate . ~. 10. -9. per base . copie...
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
by southan
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...
Endocrine resistance: molecular pathways and rational development of targeted therapies
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. Università di Napoli Federico II. ...
Wednesday, March 25 th , 2020
Wednesday, March 25 th , 2020
by amber
ncoda.org. ncoda.org. Zoom Controls. ncoda.org. St...
In-Silico and In-Vitro
In-Silico and In-Vitro
by Rebelious
. Study of Benzanilide Derivatives as a Potent . A...
Smoking-related lung disease in 3D: not your standard lecture
Smoking-related lung disease in 3D: not your standard lecture
by FuzzyWuzzyBear
Dani. S. . Zander. , MD. Professor and Chair, Dep...
MET receptor inhibition
MET receptor inhibition
by emma
in . solid. . tumors. Roberto Bianco. Università...
Way of the Wizard: Deploying
Way of the Wizard: Deploying
by jainy
Genomics in Pathology for Precision Medicine in Ca...
httpsmedlineplusgovgeneticshttpsmedlineplusgovgenetics
httpsmedlineplusgovgeneticshttpsmedlineplusgovgenetics
by eddey
1 EGFR gene epidermal growth factor receptor Norma...
Nanotek & Expo 2014
Nanotek & Expo 2014
by DaintyLittlePrincess
Biodegradable . nanobrushes. for drug delivery. ...
Beth Sandy, MSN, CRNP Nurse Practitioner
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
Award Number DAMD170310673
Award Number DAMD170310673
by barbara
AD TITLE: Development of a Microfluidic Device for...
by warlikebikers
cancer. , right vs . left. : . how. to take . it....
Please note, these are the
Please note, these are the
by disclaimercanon
actual. . video-recorded proceedings from the . l...
NCI-Molecular Analysis for Therapy Choice
NCI-Molecular Analysis for Therapy Choice
by phoebe-click
(NCI-MATCH or EAY131). Interim Analysis Results....
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...
David R.
David R.
by alida-meadow
Gandara. , MD. University of California, Davis . ...